The UK-India collaboration in the field of AMR was launched last November by UK Minister of State for Universities, Science, Research and Innovation Jo Johnson and then minister for science and technology Harsh Vardhan, Research Councils UK (RCUK) India said.
"During the meeting, the strategic group also assessed the progress made in the partnership since its launch," it said.
Antimicrobial resistance (AMR) is the ability of a microorganism (such as bacteria, viruses, and some parasites) to stop an antimicrobial agent (such as antibiotics, antivirals and antimalarials) from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others.
"The RCUK and the DBT are nodal agencies coordinating this initiative with other research funding partners in India like the Department of Science and Technology, Indian Council of Social Science Research, Indian Council of Medical Research, Indian Council of Agricultural Research and Ministry of Environment, Forests and Climate Change," RCUK India said in a statement.
More From This Section
The first meeting of the group was held in November 2016. Since then it has successfully commissioned a mapping report on AMR research in India, which was released by Johnson and Union Minister of State for Science and Technology and Earth Sciences Y S Chowdary in New Delhi last week.
"AMR research experts from the UK and India also participated in a UK-India sandpit-style workshop this week to develop outline proposals for research. The workshop, organised by the RCUK and the DBT from November 7 to 10 in Delhi-NCR, will serve as a platform to build interdisciplinary research teams and joint outline proposals for research into various aspects of AMR," it said.
"The challenge AMR poses is enormous from India's perspective because it revolves not only around the use of antibiotics, but also around enforcement, industrial waste and use of antibiotics in the livestock industry, all of which, in turn, affects the food chain and public water supply, thereby causing major health risks.
"Our research efforts are addressing the detection, diagnosis and prevalence of AMR. Our international partnerships are crucial to help scale up these efforts," K Vijay Raghavan, Secretary DBT, was quoted as saying in the statement.